Hospital Quironsalud Barcelona | Internal Medicine Department

Research site
Plaza Alfonso Comin 5-7, Barcelona, Barcelona, Spain
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


10 of 17
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

The purpose of this study is to evaluate the safety and tolerability of INCB099280 in combination with adagrasib and to establish the MTD or identify...

Advanced Solid Tumors
Drug: adagrasib
Drug: INCB099280
Locations recently updated

This study is being conducted to evaluate the safety and tolerability of INCB099280 in combination with axitinib and to assess the antitumor activity...

Advanced Solid Tumors
Drug: INCB099280
Drug: axitinib

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their cancer:cannot be...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

This Phase 3, randomized, Double-blind, placebo-controlled, 2-arm, parallel-group, multicenter study with randomized withdrawal will evaluate the eff...

Active, not recruiting
Chronic Kidney Diseases
Drug: KBP-5074
Drug: Placebo
Locations recently updated

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Castration Resistant Prostate Cancer (CRPC)
Follicular Lymphoma (FL)
Drug: PF-06821497

This is a multicenter, open-label, single-arm study to investigate the safety, tolerability, PK, pharmacodynamics and preliminary activity of INCA324...

Advanced Malignancies
Drug: INCA32459-101

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in...

Active, not recruiting
Solid Tumor
Drug: Magrolimab
Drug: Docetaxel

The main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of...

Non Small Cell Lung Cancer
Drug: Taletrectinib
Recently updated

This study will compare DS-8201a to physician choice standard treatment.Participants must have HER2-low breast cancer that has been treated before.Pa...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Capecitabine

Trial conditions

Breast Cancer (4 trials)
Cancer (4 trials)
Hypertension (2 trials)
Adenocarcinoma (1 trial)
Allergic Rhinitis (1 trial)
COVID-19 (1 trial)
Chronic Renal Insufficie... (1 trial)
Conjunctivitis (1 trial)
Diabetes Mellitus (1 trial)
Dyslipidemias (1 trial)

And 15 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems